Tennessee Center for AIDS Research (TN-CFAR)
田纳西州艾滋病研究中心 (TN-CFAR)
基本信息
- 批准号:10617275
- 负责人:
- 金额:$ 209.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:Academic Medical CentersAcquired Immunodeficiency SyndromeAddressAffectAfrican American populationAreaCollaborationsCommunitiesDataDevelopmentDisease OutbreaksDoctor of PhilosophyEnvironmentEpidemicExtramural ActivitiesFosteringFundingGoalsHIVHIV InfectionsHIV SeronegativityHIV/AIDSHealthHealth SciencesInstitutionKnowledgeLawsLeadershipMedicalMinority GroupsMissionNeedle-Exchange ProgramsPersonsPopulations at RiskPostdoctoral FellowPublic PolicyResearchResearch PersonnelResourcesRuralScienceScientistSoutheastern United StatesTennesseeUnderserved PopulationUnited StatesUnited States National Institutes of HealthVisionWorkcareer developmentcommunity engaged researchcommunity engagementcommunity organizationscommunity partnershipdashboarddesignexperiencefallshigh riskimplementation scienceimprovedmedical schoolsmultidisciplinarynext generationnovelpreventsuccesssurveillance datasynergismtooltranslational impactworking group
项目摘要
Overall – PROJECT SUMMARY
Decades of research have generated knowledge and tools with the potential to prevent all new HIV infections,
to ultimately end the HIV epidemic in the United States and worldwide, and to improve the lives of people living
with HIV. To date, reality has fallen short of these goals, in part due to pressing unmet needs. The Tennessee
Center for AIDS Research (CFAR) is located in the Southeastern United States, the region with the greatest
number of new HIV infections, and of persons living with HIV. This CFAR was established in 2015, under the
leadership of Prof. Simon Mallal, as a three-way partnership between a research-intensive medical institution
(Vanderbilt University Medical Center, VUMC), a historically black medical college (Meharry Medical College,
MMC), and an academically engaged state health department (Tennessee Department of Health, TDH). This
partnership has fostered collaborations that would be unimaginable without CFAR. For example, results of an
analysis by VUMC and MMC investigators using TDH surveillance data has affected statewide public policy and
law regarding needle exchange, reducing the likelihood of a potentially devastating HIV outbreak in rural
Tennessee. To end the epidemic, it is becoming increasingly important to pursue community-engaged research,
to include both people living with HIV and those at high risk. Toward this end, this CFAR has newly partnered
with a fourth institution, Nashville CARES, a sophisticated community-based organization with a 25-year
exclusive focus on people living with HIV and those at high risk. Through this four-way partnership, our vision is
to have transformative, local and global translational impact. Guided by this vision, our mission is to coordinate
the complementary institutional and community strengths and resources of VUMC, MMC, TDH and CARES to
most effectively reduce the burden of HIV/AIDS and generalize these benefits nationally and globally. Work of
this CFAR aligns with National Institutes of Health high priorities for NIH/AIDS research. To fulfill our mission,
this CFAR will pursue four specific aims: 1) To support multidisciplinary HIV research that leverages the highly
collaborative local environment to build impactful team science among the four institutions of the CFAR; 2) To
nurture and support career development of junior investigators, so as to grow the number and diversity of the
next generation of HIV researchers; 3) To specifically enable HIV research opportunities for MMC investigators,
to include engagement with investigators and resources across the CFAR, and leveraging team science; and 4)
To continue to grow a broad emphasis on HIV-focused community-engaged research that pervades the CFAR,
and with a focus on ending the epidemic.
总体 - 项目摘要
数十年的研究产生了知识和工具,有可能防止所有新的艾滋病毒感染,
最终结束了美国和全球的艾滋病毒流行,并改善生活的人们的生活
与艾滋病毒。迄今为止,现实未达到这些目标,部分原因是迫切需要未满足的需求。田纳西州
艾滋病研究中心(CFAR)位于美国东南部,该地区最大
新的艾滋病毒感染和艾滋病毒感染者的数量。该CFAR成立于2015年,根据
西蒙·马拉尔(Simon Mallal)教授的领导,作为研究密集型医疗机构之间的三向伙伴关系
(VUMC范德比尔特大学医学中心),一所历史悠久的黑人医学院(Meharry医学院,
MMC)和一个学术参与的州卫生部(田纳西州卫生局,TDH)。这
合作伙伴关系促进了没有CFAR的合作,这将是无法想象的。例如,
VUMC和MMC调查人员使用TDH监视数据进行了分析,影响了全州范围的公共政策和
有关针头交换的法律,减少了农村中潜在毁灭性艾滋病毒爆发的可能性
田纳西州。为了结束流行病,购买社区参与研究的越来越重要,
包括艾滋病毒感染者和高风险的人。为此,此CFAR已新合作
纳什维尔(Nashville)拥有第四个机构,是一个成熟的社区组织,拥有25年
专注于艾滋病毒和高风险的人。通过这种四向伙伴关系,我们的愿景是
具有变革性,本地和全球翻译影响。在这个愿景的指导下,我们的使命是协调
VUMC,MMC,TDH的互补机构和社区优势和资源都在乎
最有效地减少了艾滋病毒/艾滋病的伯恩(Burnen),并在全国和全球范围内概括这些好处。工作
该CFAR与美国国立卫生研究院(NIH/AIDS)研究的高度优先事项保持一致。履行我们的使命,
该CFAR将追求四个具体目标:1)支持多高学科的艾滋病毒研究
在当地环境中,在CFAR的四个机构中建立有影响力的团队科学; 2)到
护士和支持初级调查人员的职业发展,以增加
下一代艾滋病毒研究人员; 3)专门为MMC研究者提供HIV研究机会,
包括与CFAR的调查人员和资源的参与以及利用团队科学;和4)
为了继续对以HIV为重点的社区参与研究的研究遍及CFAR,
并重点是结束流行病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Koethe其他文献
John Koethe的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Koethe', 18)}}的其他基金
Cardiometabolic Consequences And Pathway Of Weight Gain Associated With Dolutegravir-Based Antiretroviral Therapy In Haiti. A Collaborative Study Between GHESKIO And CCASAnet
海地基于多替拉韦的抗逆转录病毒治疗相关的心脏代谢后果和体重增加途径。
- 批准号:
10750906 - 财政年份:2023
- 资助金额:
$ 209.58万 - 项目类别:
Ectopic Lipid in Skeletal Muscle is Associated with Glucose Intolerance in Veterans with HIV
骨骼肌中的异位脂质与感染艾滋病毒的退伍军人的葡萄糖不耐受有关
- 批准号:
10417013 - 财政年份:2020
- 资助金额:
$ 209.58万 - 项目类别:
Ectopic Lipid in Skeletal Muscle is Associated with Glucose Intolerance in Veterans with HIV
骨骼肌中的异位脂质与感染艾滋病毒的退伍军人的葡萄糖不耐受有关
- 批准号:
9885568 - 财政年份:2020
- 资助金额:
$ 209.58万 - 项目类别:
Ectopic Lipid in Skeletal Muscle is Associated with Glucose Intolerance in Veterans with HIV
骨骼肌中的异位脂质与感染艾滋病毒的退伍军人的葡萄糖不耐受有关
- 批准号:
10651630 - 财政年份:2020
- 资助金额:
$ 209.58万 - 项目类别:
The Role of Adipose-Resident T Cells in HIV-Associated Glucose Intolerance
脂肪驻留 T 细胞在 HIV 相关葡萄糖不耐受中的作用
- 批准号:
9429306 - 财政年份:2017
- 资助金额:
$ 209.58万 - 项目类别:
The Role of Adipose-Resident T Cells in HIV-Associated Glucose Intolerance
脂肪驻留 T 细胞在 HIV 相关葡萄糖不耐受中的作用
- 批准号:
10093023 - 财政年份:2017
- 资助金额:
$ 209.58万 - 项目类别:
Innate and Adaptive Immunity in HIV-associated Impaired Glucose Tolerance and Diabetes
HIV 相关糖耐量受损和糖尿病中的先天免疫和适应性免疫
- 批准号:
9260968 - 财政年份:2015
- 资助金额:
$ 209.58万 - 项目类别:
相似海外基金
The Gut-Liver Axis in HIV-Related Non-Alcoholic Fatty Liver Disease
HIV 相关非酒精性脂肪肝中的肠肝轴
- 批准号:
10762284 - 财政年份:2023
- 资助金额:
$ 209.58万 - 项目类别:
The Hektoen Institute of Medical Research Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
Hektoen 医学研究所站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10709606 - 财政年份:2022
- 资助金额:
$ 209.58万 - 项目类别:
Meharry HIV/AIDS Research and Training Facility
梅哈里艾滋病毒/艾滋病研究和培训设施
- 批准号:
10547968 - 财政年份:2022
- 资助金额:
$ 209.58万 - 项目类别:
The Hektoen Institute of Medical Research Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
Hektoen 医学研究所站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10599560 - 财政年份:2022
- 资助金额:
$ 209.58万 - 项目类别:
Enhancing Virology Training of Underrepresented Minority Students through Summer Research
通过暑期研究加强对代表性不足的少数民族学生的病毒学培训
- 批准号:
10313298 - 财政年份:2021
- 资助金额:
$ 209.58万 - 项目类别: